[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593703":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":27,"locations":32,"responsibleParty":51,"collaborators":22,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":22,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":22,"enrollmentInfo":61,"targetDuration":22,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":22,"overallStatus":35,"whyStopped":22,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TA-DA","EXPERIMENTAL","Patient and caregiver participants are presented with a prototype version of TA-DA and participate in interviews over 90 minutes to further refine the tool.",[13],"Other: Communication",{"label":15,"type":10,"description":11,"interventionNames":16},"EUC",[13],[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"Communication","Participants meet with clinician",[15,9],null,[24],{"name":25,"affiliation":5,"role":26},"David Hui, MD","PRINCIPAL_INVESTIGATOR",[28],{"name":25,"role":29,"phone":30,"phoneExt":22,"email":31},"CONTACT","(713) 792-6258","dhui@mdanderson.org",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"The University of Texas M. D. Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-95.36327,29.76328,{"lat":45,"lon":44},[48,50],{"name":25,"role":29,"phone":49,"phoneExt":22,"email":31},"713-792-6258",{"name":25,"role":26,"phone":22,"phoneExt":22,"email":22},{"type":52,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100593703","development-of-an-educational-patient-decision-aid-treatments-in-advanced-cancer---decision-aid-ta-da-to-promote-shared-decision-making-for-third-line-or-beyond-palliative-systemic-therapy-100593703",false,"NCT07009886","Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy","Inclusion Criteria:\n\n1. Clinicians (Part I\u002FII\u002FIII):\n\n   MD Anderson medical oncologists and APPs who provide care to patients with advanced cancer\n2. Patients (Part I\u002FII\u002FIII):\n\n   Age 18 or over\n   * Diagnosis of advanced cancer (i.e., metastatic, relapsed, and\u002For incurable disease as defined by the treating oncologist) who has received at least 2 lines of palliative systemic therapy\\*\n   * Patient-rated ECOG performance status of 1-3 for Part I\u002FII and 2-3 for Part III\n   * Able to make treatment decisions based on the clinical judgement of the oncology team\n   * English speaking\n\n     * patient has started, is receiving, and\u002For has completed second-line palliative systemic therapy or beyond\n3. Caregivers (Part I\u002FII\u002FIII):\n\n   * Age 18 or older\n   * Currently a primary caregiver to a patient who satisfies the patient eligibility criteria listed above\n   * For the study purposes, a primary caregiver is defined as:\n\n     * someone who provides physical, emotional, decisional and\u002For logistical assistance to the patient regularly (e.g. daily, weekly);\n     * can be a family member, friend, or other individual in a close relationship with the patient;\n     * must be identified by the patient and self-identify as the primary person providing caregiving support to the patient\n   * Able to provide informed consent and participate in the study\n   * English speaking\n\nExclusion Criteria:\n\nAny patient who meets any of the following criteria will be excluded from participation in this study:\n\n* (Part I\u002FII\u002FIII): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team\n* (Part III only): Participants in Part I and II","ALL","18 Years",{"count":62,"type":63},155,"ESTIMATED","INTERVENTIONAL",[66],"NA","To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).",[69],"Advanced Cancer","2026-08-10",{"date":72,"type":73},"2026-08-12","ACTUAL",{"date":75,"type":73},"2025-07-10",{"date":77,"type":63},"2030-07-31",{"name":5,"class":6},1]